Further, Ligumsky et al. identified GLP-1 as a potent inducer of cyclic adenosine monophosphate and an inhibitor of breast cancer cell proliferation, suggesting that reduced GLP-1 levels may serve as a novel link between obesity, diabetes mellitus, and breast cancer13. The gene discussed is GLP1R; the disease is obesity disorder.